The development of mesenchymal stem cells (MSCs) as cell-based drug delivery vectors for
numerous clinical indications, including cancer, has significant promise. However, a …

Background: Glioblastoma multiforme (GBM) is the most common and lethal primary
malignancy of the central nervous system (CNS). Despite the proven benefit of surgical …

Mesenchymal stem cells (MSCs) can exhibit a marked tropism towards site of tumors. Many
studies have reported that tumor progression and metastasis increase by MSCs. In contrast …

Introduction Glioblastoma is the most common primary malignant brain tumor, and is
refractory to surgical resection, radiation, and chemotherapy. Human mesenchymal stem …

Mesenchymal stem cells (MSCs) show homing capacity towards tumor sites. Numerous
reports indicate that they are involved in multiple tumor-promoting processes through …

Oncolytic virotherapy is a promising alternative to conventional treatment, yet systemic
delivery of these viruses to tumors remains a major challenge. In this regard, mesenchymal …

There is currently much interest in adult mesenchymal stem cells (MSCs) and their ability to
differentiate into other cell types, and to partake in the anatomy and physiology of remote …

Background Mesenchymal stem cells (MSC) can serve as carriers to deliver oncolytic
measles virus (MV) to ovarian tumors. In preparation for a clinical trial to use MSC as MV …

Mesenchymal stem cells have a natural tropism for tumours and their metastases, and are
also considered immunoprivileged. This remarkable combination of properties has formed …

Importance of the field: Mesenchymal stem cells have the ability to differentiate into
osteoblasts, chondrocytes and adipocytes. Along with differentiation, MSCs can modulate …